AstraZeneca Aktie
123,85
EUR
-2,40
EUR
-1,90
%
1.423,00
SEK
-24,00
SEK
-1,66
%
AstraZeneca Aktie Analyse
| 30.04.20 | AstraZeneca Reduce | HSBC | |
| 29.04.20 | AstraZeneca Sell | UBS AG | |
| 29.04.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.04.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 27.04.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 23.04.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 21.04.20 | AstraZeneca buy | Kepler Cheuvreux | |
| 17.04.20 | AstraZeneca Outperform | Credit Suisse Group | |
|
Werbung
|
|||
| 15.04.20 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 14.04.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 14.04.20 | AstraZeneca buy | Deutsche Bank AG | |
| 14.04.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 09.04.20 | AstraZeneca overweight | Barclays Capital | |
| 07.04.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 06.04.20 | AstraZeneca buy | Deutsche Bank AG | |
| 03.04.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 31.03.20 | AstraZeneca buy | Deutsche Bank AG | |
| 31.03.20 | AstraZeneca buy | Oddo BHF | |
| 30.03.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 20.03.20 | AstraZeneca buy | Deutsche Bank AG | |
| 17.03.20 | AstraZeneca overweight | Barclays Capital | |
| 12.03.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 09.03.20 | AstraZeneca Sell | UBS AG | |
| 09.03.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 06.03.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 25.02.20 | AstraZeneca buy | Deutsche Bank AG | |
| 18.02.20 | AstraZeneca buy | Kepler Cheuvreux | |
| 17.02.20 | AstraZeneca Sell | UBS AG | |
| 17.02.20 | AstraZeneca buy | Deutsche Bank AG | |
| 17.02.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 14.02.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 14.02.20 | AstraZeneca overweight | Barclays Capital | |
| 14.02.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 14.02.20 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 05.02.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 03.02.20 | AstraZeneca Sell | UBS AG | |
| 31.01.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 28.01.20 | AstraZeneca buy | Deutsche Bank AG | |
| 27.01.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 23.01.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 22.01.20 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 16.01.20 | AstraZeneca overweight | Barclays Capital | |
| 16.01.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 06.01.20 | AstraZeneca neutral | Morgan Stanley | |
| 06.01.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 17.12.19 | AstraZeneca Outperform | Credit Suisse Group | |
| 17.12.19 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 12.12.19 | AstraZeneca Sell | UBS AG | |
| 12.12.19 | AstraZeneca buy | Deutsche Bank AG | |
| 11.12.19 | AstraZeneca Hold | Jefferies & Company Inc. | |